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Figure 1. Our project-speciﬁc database utilized CTCAE drop down menus to improve the collection of adverse event data. This capability will be enhanced and built
into our EMR, Epic.
Table 1
ANC Recovery Comparison
2003
(n[ 33)
2013
(n[ 72)
ANC Recovery Inpatient 26 (79%) 45 (63%)
ANC Recovery Post-Discharge 7 (21%) 27 (38%)
Daily Labs Drawn Until ANC
 0.5 x109/L Post-Discharge
5 (15%) 0
Abstracts / Biol Blood Marrow Transplant 21 (2015) S240eS265S264 0.5 x109/L returned for daily lab draws. For patients in
this subset, we discovered a gap in the number of days
between their last lab showing ANC < 0.5 x109/L and
their ﬁrst lab showing ANC  0.5 x109/L. The upward
trend in days to ANC recovery was not because of
delayed ANC recovery, but due to increasing days be-
tween lab draws.ANC  0.5 x109/L With Non-Daily
Lab Draws
2 (6%) 27 (38%)
ANC  0.5 x109/L With Daily Lab Draws 31 (94%) 45 (63%)
Days between last lab ANC
< 0.5 x109/L <500 and ﬁrst
lab ANC  0.5 x109/L
1-2 1-19
Table 2
Days to ANC Recovery
2003
(n[33)
2013
(n[72)
2013 Daily
Labs (n[45)
2013 Non-Daily
Labs (n[27)
Average 11 15 12 21
Median 11 13 11 20
Range 9-15 10-42 10-16 15-42
We propose adding a reporting ﬁeld to capture date of last lab showing ANC
< 0.5 x109/L. This would help identify when a delay in lab draw occurred
leading to the realization that ANC recovery may have been earlier than
indicated.374
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Background: The University of Maryland Blood and
Marrow Transplant (BMT) team has a reputation of estab-
lishing a culture of continuous quality improvement to
assure the utmost accuracy of CIBMTR data. In early 2012,
Minas and Ruehle reported the signiﬁcance of auditing 10
commonly used data points. In early 2013, Minas and
Ruehle set out to further improve CIBMTR data accuracy by
combining their original set of commonly used data points
with 19 additional ones. In early 2014, Minas and Ruehle
developed a survey to explore the internal assessment
audit activities utilized by 137 CIBMTR afﬁliated transplant
centers.
Methods: To manage any current or possible data quality
issues at transplant centers CIBMTR performs an audit every
four years. CIBMTR randomly selected 16 University ofMaryland BMT transplants for audit in 2014. To be eligible for
audit, one of the following form combinations must be
submitted to the outcomes registry: Pre-Transplant Essential
Abstracts / Biol Blood Marrow Transplant 21 (2015) S240eS265 S265Data (TED), 100 Day Post-TED Forms (Form 2400 and Form
2450), and CIBMTR Case Report Forms (Form 2000 and Form
2100). To pass a CIBMTR audit the critical ﬁeld rate must be
less than or equal to 3%.
Results: University of Maryland BMT team passed with a
critical data ﬁeld rate of 1.6%. The random data ﬁeld error rate
was 2%, and the overall data ﬁeld error rate was 1.7%. Out of
7,632 overall ﬁelds audited there was an error total of 132
(1.7%). Of the 5,956 critical data ﬁelds audited the error total
was 98 (1.6%). The remaining 1,676 random data ﬁelds
audited had an error total of 34 (2%). Of the 1.6% critical data
ﬁelds, the identiﬁed ﬁeld errors were categorized as follows:
GVHD (30.6%), disease status (24.5%), latest disease
assessment (22.4%) and miscellaneous critical ﬁeld errors
(22.5%). The consent formswere 100% accurate. Therewas no
corrective action required. Some of the random data ﬁeld
error trends included the reporting of co-morbid conditions
and post-HCT therapy.
Conclusion: Internal assessments have been well worth the
time and effort of the data managers for external audits.
Why? Our FACT (Foundation for the Accreditation of Cellular
Therapy) audit was 100% accurate, which we attribute to the
continuous quality improvement of CIBMTR data. Moreover,
in February 2014, the CIBMTR audit resulted in an excellent
critical error rate which is important in maintaining the
highest levels of excellence.375
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Introduction: Accurate data collection is essential for the
validity in use of scientiﬁc data entered in databases (DB).
From an earlier study we identiﬁed the difﬁcult task in
entering accurate data to local and international databases.
We therefore decided to examine which tools we have
available to collect the data.
We frequently participate in requests from CIBMTR,
EBMT, local DB and we enter patients into clinical research
protocols, all tasks where data collection is necessary.
The patient ﬁle is in a paper and an electronic version. The
paper version is documents which either have not been
converted nor been able to convert into an electronic version.Within the patient paper ﬁle there is already a document
to list essential data for data registering, and since the
electronic patient ﬁle has been implemented, the awareness
of paper documents has declined.
Currently some data are collected solely by the data
managers (DM) and extracted from patient ﬁles at the
hospital and from national patient registries. Some data,
however, must be reviewed and interpreted by a physician in
order to extract valid data. Therefore, it is necessary for the
treating physician to have an overview of which data is
essential to list in the patient ﬁle.
The BMT unit is preparing for JACIE accreditation and
according to standard B9.1: “The Clinical Programmust furnish
evidence of its own periodic data audits to determine if data are
accurate for evaluation of patient outcomes” e.g. outcome
analysis on day +100, +180 and annually.
Aim: To optimize data collection to increase validity of data
entered to CIBMTR, EBMT, DB and CRF's.
To identify which data are to be collected and entered in
CIBMTR, EBMT, DB and Clinical Research Files (CRF).
To create an overview of which data are to be collected to
DB and CRF's to ease the data collection at patient visits.
Method: We reviewed forms from the CIBMTR, EBMT
and CRF's from the clinical research team and listed
which essential data are needed on day +100, +180 and
annually.
We identiﬁed and reviewed existing paper documents in
the patient paper ﬁle, which previously has been created to
give an overview of which data to be collected and also to
enter data on by the treating physician.
By looking into our electronic patient ﬁle system, we
discovered the possibility to create standard notes.
Results: The existing paper document is now changed to a
schedule to give an overview of which data to be collected on
day +100, +180 and annually. The schedule is put in the
patient paper ﬁle and data collection is divided into: Data
collected by treating physician and data collected by data
manager.
Within the electronic patient ﬁle we created standard
notes. The physician can click on the relevant day of visit
and view which data to be entered on the speciﬁc
dates of patient visits. From here the DM can extract the
data.
To implement the new schedules and notes in the patient
ﬁle, we had a meeting with the BMT-physicians.
